Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

02:00 ET ERBA Mannheim lance les kits pour la détection d'anticorps ELISA COVID-19 possédant un marquage CE - L'autorisation d'utilisation en urgence de la FDA suivra prochainement

En réponse à la pandémie mondiale du COVID-19, Erba Mannheim a annoncé aujourd'hui le développement et le lancement imminent de ses kits ELISA...


02:00 ET ERBA Mannheim lanza los kits ELISA de anticuerpos de COVID-19

En respuesta a la pandemia global de COVID-19, Erba Mannheim anunció hoy el desarrollo y el inminente lanzamiento de sus kits ErbaLisa? COVID-19...


02:00 ET ERBA Mannheim bringt COVID-19-Antik?rper-ELISA-Kits mit CE-Zeichen auf den Markt - FDA-EUA wird bald folgen

Als Reaktion auf die globale COVID-19-Pandemie gab Erba Mannheim heute die Entwicklung und die bevorstehende Einführung seiner ErbaLisa?...


00:21 ET Alligator Bioscience Presents Promising Interim Phase I Data for its Bispecific Drug Candidate ATOR-1015 at AACR

Alligator Bioscience (Nasdaq Stockholm: ATORX), announces that the company today presents the status of the ongoing Phase I clinical trial with the...


00:01 ET Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise...


00:01 ET I-SPY2 TRIAL Demonstrates Significant Improvement in pCR with Durvalumab and Olaparib with Paclitaxel, (Compared to Chemotherapy Alone) in Women with Stage II/III High-Risk, HER2-Negative Breast Cancer, in HR+ and TNBC Subsets

I-SPY 2 TRIAL researchers presented results on April 27 at the clinical trial plenary session of the American Association for Cancer Research (AACR)...


Apr 26, 2020, 21:40 ET Halozyme Announces Janssen Submits New Drug Application In Japan For Daratumumab Subcutaneous Formulation Utilizing Halozyme's ENHANZE? Technology For Patients With Multiple Myeloma

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the submission of a New Drug Application (NDA) to the Ministry of Health, Labour and...


Apr 24, 2020, 17:21 ET Hackensack Meridian Health Develops RE-COV-RY (Real world Evidence - COVid-RegistrY) to Study the Effects of COVID-19 and Releases Key Findings on Hypertension and ACE/ARB Treatments

Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, conducted an observational real world study of more than...


Apr 24, 2020, 16:36 ET AdaptVac schie?t sich mit AGC Biologics zusammen, um COVID-19-Impfstoff zu entwickeln und zu produzieren

GC Biologics, ein führender Anbieter im Bereich der biopharmazeutischen Auftragsentwicklung und Fertigung (Biopharmaceutical Contract Development and ...


Apr 24, 2020, 15:38 ET BGI Expands EUA Label for SARS-CoV-2 RT-PCR Test with MGI Automated Extraction Methods and Additional PCR Systems

BGI Genomics. Co. Ltd. (SZSE:300676) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for expanding its ...


Apr 24, 2020, 14:34 ET AdaptVac s'associe à AGC Biologics pour développer et produire un vaccin contre le COVID-19

AGC Biologics, un fa?onnier biopharmaceutique (Biopharmaceutical Contract Development and Manufacturing Organization - CDMO) mondial, a annoncé son...


Apr 24, 2020, 11:42 ET ClinCapture Joins Forces with MediciNova to Support their COVID-19 Research

ClinCapture, Inc. a leading provider in Electronic Data Capture (EDC) systems, and biopharmaceutical company MediciNova, Inc. have joined forces in...


Apr 24, 2020, 11:29 ET Signifier Medical Technologies arbeitet bei seinen klinischen Studien für das innovative Ger?t Snoozeal? mit Schlafexperten aus aller Welt zusammen

Signifier Medical Technologies, ein Innovator auf dem Markt für schlafbezogene Atmungsst?rungen, gab heute bekannt, dass das Unternehmen mit 27...


Apr 24, 2020, 11:25 ET Signifier Medical Technologies collabore avec des spécialistes du sommeil mondiaux dans le cadre de ses essais cliniques sur le dispositif Snoozeal? innovant

Signifier Medical Technologies, une société novatrice sur le marché des troubles respiratoires du sommeil, a annoncé aujourd'hui son partenariat avec ...


Apr 24, 2020, 10:58 ET Sumitovant Biopharma Reports Key Clinical and Regulatory Milestones by Myovant Sciences

Sumitovant Biopharma Ltd. today announced that Myovant Sciences, one of five healthcare companies in the Sumitovant family of companies, achieved...


Apr 24, 2020, 09:43 ET Hoth Therapeutics, Inc., Voltron Therapeutics, Inc., & HaloVax Announce Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine

Hoth Therapeutics, Inc. (Nasdaq: HOTH) announced today that Voltron Therapeutics, Inc has selected the peptides required to complete the structure of ...


Apr 24, 2020, 09:17 ET Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA? (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to ...


Apr 24, 2020, 08:30 ET Evofem Biosciences Announces Three New Phexxi? Data Sets Accepted for Presentation at the 2020 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting

Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company, today announced that three new data sets from the Company's...


Apr 24, 2020, 08:28 ET AdaptVac se asocia con AGC Biologics para desarrollar y producir una vacuna para el COVID-19

AGC Biologics, una organización biofarmacéutica de fabricación y desarrollo por contrato global (CDMO), anunció su asociación con AdaptVac para...


Apr 24, 2020, 07:04 ET Vela Diagnostics receives CE mark for COVID-19 detection test

Vela Diagnostics announced today that the manual version of the ViroKey? SARS-CoV-2 RT-PCR Test has received the CE mark for in vitro diagnostic use. ...


Apr 24, 2020, 02:50 ET AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine

AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with AdaptVac to...


Apr 23, 2020, 16:45 ET Human Vaccines Project Launches Global Initiative to Accelerate the Development of COVID-19 Vaccines for Those Most Vulnerable

The Human Vaccines Project (HVP), a global nonprofit consortium is launching the COVID Vaccine Initiative (CVI), with the goal to ensure the...


Apr 23, 2020, 14:00 ET COVID-19 Antibody Therapy Treatment Advances At SCL Health

As providers in the healthcare industry continue work to develop effective treatments for COVID-19, SCL Health is advancing critical work with the...


Apr 23, 2020, 11:54 ET First Patient in Treatment in RhoVac's Clinical Phase IIb Study in Germany

RhoVac AB ("RhoVac") announces today, on 23rd April 2020, that the first patient in Germany is in treatment in the company's clinical phase IIb study ...


Apr 23, 2020, 11:45 ET Signifier Medical Technologies colabora con los expertos del sue?o mundiales

Signifier Medical Technologies, innovador dentro del mercado de la enfermedad respiratoria del sue?o, anunció hoy su asociación con 27 líderes de...